In8bio Inc (INAB) Directors and Executive Officers - CSIMarket
CSIMarket
 
In8bio Inc   (NASDAQ: INAB)

In8bio Inc

Officers & Directors


Patrick McCall
Chief Financial Officer and Secretary - (Principal Financial and Accounting Officer)

William Ho
Chief Executive Officer and Director - (Principal Executive Officer)

Travis Whitfill
Director -

Jeremy R. Graff
Director -

Emily Fairbairn
Director -

Peter Brandt
Director -

Alan S. Roemer
Chairman of the Board of Directors -

Luba Greenwood
Director -

Corinne Epperly
Director -

CohnRenzick LLP
We have served as the Company’s auditor - since ,

In8bio Inc currently has 17 employees.

  News about In8bio Inc Key Personnel

IN8bio's Resolute Focus on INB-100 Ignites Hope for Acute Myeloid Leukemia Patients amid Financial Hurdles,

IN8bio s Strategic Prioritization: Focusing on INB-100 for Acute Myeloid Leukemia amidst Market Challenges
In a recent announcement, IN8bio Inc unveiled its clinical pipeline prioritization strategy, with an emphasis on INB-100, a potential breakthrough therapy for Acute Myeloid Leukemia (AML). As the company aims to address the pressing need for effective treatments in this field, INB shares have reached their lowest point in the past 52 weeks. Furthermore, IN8bio s financial performance during the third quarter of 2023 shows a significant net loss and a negative return on assets (ROA).
The prioritization of INB-100 reflects IN8bio s commitment to advancing innovative solutions for the treatment of...






INAB Management Effectiveness INAB Revenue per Employee INAB Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.